Pathstone Holdings
CTSO icon

Pathstone Holdings’s Cytosorbents Corp CTSO Stock Holding History

Pathstone Holdings’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$187K Sell
499,910
-45
-0% -$24 ﹤0.01% 2246
2026
Q1 		$283K Hold
499,955
– – ﹤0.01% 1997
2025
Q4 		$320K Buy
+499,955
New +$385K ﹤0.01% 1932

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM

Pathstone Holdings's CTSO Position: Q2 2026 in Review

Pathstone Holdings reduced its Cytosorbents Corp (CTSO) stake by 0.01% in Q2 2026, selling an estimated $24 and leaving 499,910 shares worth $187K. The position accounts for ﹤0.01% of the portfolio, ranked #2246.

Pathstone Holdings first reported a position in CTSO in Q4 2025 and has held it in 3 quarters since. The position peaked at $320K in Q4 2025. 51 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • Pathstone Holdings held 499,910 shares of Cytosorbents Corp worth $187K as of Q2 2026.
  • Pathstone Holdings sold 45 Cytosorbents Corp shares in Q2 2026, an estimated $24.
  • Cytosorbents Corp made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #2246 holding.
  • Pathstone Holdings first reported a position in Cytosorbents Corp in Q4 2025 and has held it in 3 quarters since.
  • Pathstone Holdings's Cytosorbents Corp position peaked at $320K in Q4 2025.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.